Rarick Lisa Dale 4
4 · Evofem Biosciences, Inc. · Filed Feb 26, 2020
Insider Transaction Report
Form 4
Rarick Lisa Dale
Director
Transactions
- Award
Stock option (right to buy)
2020-02-25+75,000→ 75,000 totalExercise: $5.85Exp: 2030-02-25→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The shares of common stock exercisable pursuant to the option will vest on a monthly basis over 3 years upon completion of continuous service for the Issuer from the vesting commencement date of February 25, 2020. The option was awarded in connection with Dr. Rarick's appointment to the Issuer's Board of Directors.